Pathology
 |
|
5 november 2018 00:00:09 |
| Melphalan dose in myeloma patients >=65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry study (Bone Marrow Transplantation) |
|
Tweet |
| 571 viewsCategory: Medicine, Pathology |
 Safety and efficacy of propylene glycol-free melphalan as conditioning in patients with AL amyloidosis undergoing stem cell transplantation (Bone Marrow Transplantation)Successful engraftment in recipients of haploidentical stem cells with donor-specific antibodies: role of flow cytometric cross-match (Bone Marrow Transplantation) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
